Skip to main content

Advertisement

Table 1 Baseline patient characteristics.

From: Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Variable Type 2 diabetes
Age (years) 59
Gender (% male) 56%
BMI (kg/m2) 31.9
Weight (kg) 89.8
Height (metres) 1.67
Ethnicity (% black) 1%
Total cholesterol (mmol/L) 5.2
HDL cholesterol (mmol/L) 1.04
Systolic blood pressure (mmHg) 136
HbA1c (%) 7.1
Peripheral vascular disease (%) 30%
Smoking (%) 0
Risk of severe hypoglycaemia* 0.462
Number of nocturnal hypos (year) 2.4
Number of symptomatic hypos (year) 6.8
  1. Data from Heine et al[22], data from UKPDS baseline cohort[16], * data from Leese et al[6]